(Q34087879)

30 July 2017

1 reference

title

Preoperative endocrine therapy for older women with breast cancer: renewed interest in an old idea (English)

1 reference

30 July 2017

Ellis MJ

1

1 reference

30 July 2017

1 November 2000

1 reference

30 July 2017

1 reference

30 July 2017

7

1 reference

30 July 2017

6

1 reference

30 July 2017

557-562

1 reference

Representation of older patients in cancer treatment trials

30 July 2017

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700607

The effect of comorbidity on 3-year survival of women with primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700607

Breast cancer in elderly women: presentation, survival, and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700607

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700607

Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the Nationa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700607

Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700607

Variation of hormonal receptor, pS2, c-erbB-2 and GSTpi contents in breast carcinomas under tamoxifen: a study of 74 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700607

Tumour oestrogen receptor content allows selection of elderly patients with breast cancer for conservative tamoxifen treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700607

pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700607

Prebiopsy neo-adjuvant endocrine therapy for breast cancer to prevent post-surgery trauma-induced growth factor and immune-suppression mediated tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700607

Long-term follow-up of elderly patients with locoregional breast cancer treated with tamoxifen only

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700607

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700607

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700607

10.1177/107327480000700607

21 January 2018

Identifiers

DOI

0 references

PubMed ID

11088064

1 reference

PubMed ID

11088064